Tudor Investment Corp’s CureVac CVAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-10,070
Closed -$30.5K 2395
2024
Q1
$30.5K Sell
10,070
-2,212
-18% -$7.76K ﹤0.01% 2127
2023
Q4
$51.7K Buy
+12,282
New +$66.6K ﹤0.01% 2266
2023
Q3
Sell
-21,454
Closed -$224K 2381
2023
Q2
$224K Buy
+21,454
New +$192K ﹤0.01% 2163
2023
Q1
Sell
-14,762
Closed -$89K 2505
2022
Q4
$89K Buy
+14,762
New +$109K ﹤0.01% 2228
2022
Q3
Sell
-22,335
Closed -$304K 2371
2022
Q2
$304K Buy
22,335
+9,628
+76% +$159K 0.01% 1557
2022
Q1
$249K Buy
12,707
+3,400
+37% +$67.9K 0.01% 1651
2021
Q4
$319K Buy
+9,307
New +$374K 0.01% 1797
2021
Q3
Sell
-2,972
Closed -$218K 2507
2021
Q2
$218K Sell
2,972
-59
-2% -$5.9K ﹤0.01% 1460
2021
Q1
$277K Buy
+3,031
New +$294K 0.01% 1333

Other funds holding CVAC

Tudor Investment Corp's CVAC Position: Q2 2024 in Review

Tudor Investment Corp sold out of CureVac (CVAC) in Q2 2024, closing a stake of 10,070 shares — an estimated $30.5K sold.

Tudor Investment Corp first reported a position in CVAC in Q1 2021 and held it in 9 quarters. The position peaked at $319K in Q4 2021. 87 funds tracked by Wall St. Rank hold CVAC as of Q2 2024.

  • Tudor Investment Corp reported no remaining CureVac position as of Q2 2024 after selling out during the quarter.
  • Tudor Investment Corp sold 10,070 CureVac shares in Q2 2024, an estimated $30.5K.
  • Tudor Investment Corp first reported a position in CureVac in Q1 2021 and held it in 9 quarters.
  • Tudor Investment Corp's CureVac position peaked at $319K in Q4 2021.
  • 87 funds tracked by Wall St. Rank held CureVac as of Q2 2024.

Based on Tudor Investment Corp's 13F filing for Q2 2024, filed 14 Aug 2024.